Planned 25,613-share sale by uniQure (NASDAQ: QURE) under Rule 144

Rhea-AI Filing Summary

uniQure has a planned sale of ordinary shares under Rule 144. A person identified as Robert Gut filed to sell 25,613 ordinary shares through Citigroup Global Markets on the NASDAQ, with an aggregate market value of $676,695.00. The filing notes that there were 62,291,663 ordinary shares outstanding at the time, providing context for the sale size.

The shares to be sold include stock acquired on January 12, 2026 through a stock option exercise and sale pursuant to a Rule 10b5-1 trading plan, as well as vested share awards originally received in 2021 and 2022 as compensation from uniQure entities. The notice also discloses that Gut sold 31,434 ordinary shares on November 6, 2025 for gross proceeds of $856,881.00, as part of the required three-month sale history.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	25613	676695.00	62291663	01/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	01/12/2026	Stock Options Exercise and Sale pursuant to 10B5-1 Plan	UniQure N.A.			17810	01/12/2026	Cash
ORDINARY SHARES	02/26/2021	vested shares	Uniqure N.V.			2826	02/26/2021	Compensation
ORDINARY SHARES	01/25/2022	Vested shares	Uniqure N.V.			3812	01/25/2022	Compensation
ORDINARY SHARES	01/25/2022	vested shares	Uniqure N.V.			1165	01/25/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Gut paasheuvelweg 25 a Amsterdam P7 1105BP	ORDINARY SHARES	11/06/2025	31434	856881.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the uniQure (QURE) Form 144 filing show?

The Form 144 filing shows that a person identified as Robert Gut plans to sell 25,613 uniQure ordinary shares under Rule 144 through Citigroup Global Markets on the NASDAQ, with an aggregate market value of $676,695.00.

How many uniQure (QURE) shares are being sold and what is their market value?

The notice covers a proposed sale of 25,613 ordinary shares of uniQure, with an aggregate market value of $676,695.00 as disclosed in the filing.

Who is selling the uniQure (QURE) shares and on which exchange will they trade?

The seller named in the filing is Robert Gut, and the ordinary shares are expected to be sold on the NASDAQ stock market.

How and when were the uniQure (QURE) shares being sold originally acquired?

The filing states that some shares were acquired on January 12, 2026 via a stock option exercise and sale pursuant to a Rule 10b5-1 plan, while other shares were vested compensation awards from February 26, 2021 and January 25, 2022 from uniQure entities.

Were there any recent uniQure (QURE) share sales by this person before this Form 144?

Yes. The document reports that 31,434 ordinary shares were sold on November 6, 2025 for $856,881.00 in gross proceeds during the three months prior to this notice.

How many uniQure (QURE) ordinary shares were outstanding when this sale was noted?

The filing indicates that 62,291,663 ordinary shares of uniQure were outstanding, which serves as a baseline figure relative to the planned Rule 144 sale.

What trading plan is referenced in the uniQure (QURE) Form 144?

The acquisition table notes that part of the shares to be sold were obtained through a stock options exercise and sale pursuant to a Rule 10b5-1 plan on January 12, 2026.